No 10Y consistency score for revenue — its stored periods are half-year spaced, so quarter-over-same-quarter consistency is not computed.
Valuation vs own 10Y history: No P/S history yet
Annual revenue · last 11 fiscal years
Quarterly YoY revenue growth vs the 20% line
P/S multiple vs its 10Y median
Revenue growth
36.81%
5Y CAGR
Gross margin
74.72%
TTM
P/E ratio
N/A
trailing two half-years
P/B ratio
2.9×
Latest quarter
The latest delayed quote for Marex Group Limited (MRX) stock was $74.95 as of Oct 6, 2026, 11:25 AM EDT, down 0.35% from the previous close.
Longer view (total return, dividends reinvested): past 12 months +153.2%
Marex Group plc, a financial services platform company, provides liquidity, market access, and infrastructure services to clients in the commodity and financial markets in the United Kingdom, the United States, and internationally. It operates through Clearing, Agency and Execution, Market Making, and Hedging and Investment Solutions segments.
Financial - Capital Markets · London, GL
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
Next Earnings Date
N/A
EPS Estimate
N/A
Revenue Est.
N/A
Last Quarter Results
EPS
$1.64
vs Estimate
$1.36
Revenue
$695.80M
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR | Compare |
|---|---|---|---|---|---|---|---|
| 1MRX | $5.39B | $74.95 | -0.35% | +153.23% | N/A | N/A | N/A |
| 2OZKAP | $5.19B | $14.80 | +0.00% | -10.63% | N/A | N/A | vs MRX |
| 3RLI | $5.19B | $56.53 | +0.80% | -9.52% | +4.71% | +8.06% | vs MRX |
| 4CACC | $5.59B | $534.87 | +0.66% | +9.32% | -2.87% | +10.68% | vs MRX |
| 5FIGR | $5.14B | $28.14 | +0.70% | -30.55% | N/A | N/A | vs MRX |
| 6MAIN | $5.12B | $55.02 | +0.06% | -5.70% | +14.48% | +13.10% | vs MRX |
2.88
vs Estimate
$625.28M
Consensus Rating
Based on 8 analysts
Average Price Target
$81.00
+8.1% upside
Low
$36.00
Current
$74.95
High
$100.00
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $1.11 | $1.15 | $1.21 | 1 |
| Quarter ending Dec 2026 | $1.68 | $1.71 | $1.74 | 4 |
| Quarter ending Mar 2027 | $1.34 | $1.39 | $1.47 | 1 |
| Quarter ending Jun 2027 | $1.58 | $1.66 | $1.71 | 1 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2026 | $5.69 | $6.15 | $6.52 | 4 |
| FY 2027 | $6.13 | $6.88 | $7.35 | 5 |
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $546.16M | $561.92M | $585.52M | 1 |
| Quarter ending Dec 2026 | $711.67M | $738.68M | $756.88M | 2 |
| Quarter ending Mar 2027 | $668.31M | $687.60M | $716.47M | 1 |
| Quarter ending Jun 2027 | $713.20M | $740.27M | $758.51M | 1 |
Annual
| Period |
|---|
Source: FMP Analyst Consensus Estimates. Forward P/E uses the consensus EPS estimate for the fiscal year ending Dec 31, 2026, matching Key Metrics.
| Low |
|---|
| Avg |
|---|
| High |
|---|
| # Analysts |
|---|
| FY 2026 | $2.68B | $2.77B | $2.85B | 3 |
| FY 2027 | $2.97B | $3.04B | $3.10B | 4 |
